Investment Summary |
|
|---|---|
| Date | 2017-12-01 |
| Target | Centinel Spine |
| Sector | Medical Products |
| Investor(s) | Athyrium Capital Management |
| Deal Type | Growth Capital |
SEARCH BY
| Category | Asset Manager |
|---|---|
| Founded | 2008 |
| PE ASSETS | 4.6B USD |
| Size | Large |
| Type | Sector Focused |
Athyrium Capital Management is a large asset manager focused on the healthcare sector. Athyrium invests in a wide range of financial instruments including royalties, structured credit, and equities as well as select special situations. Athyrium Capital was established in 2008 and is headquartered in New York, New York.
| DEAL STATS | # |
|---|---|
| Overall | 28 of 50 |
| Sector: Medical Products M&A | 5 of 6 |
| Type: Growth Capital M&A Deals | 5 of 11 |
| State: Pennsylvania M&A | 3 of 4 |
| Country: United States M&A | 26 of 45 |
| Year: 2017 M&A | 7 of 7 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-11-07 |
Biora Therapeutics
San Diego, California, United States Biora Therapeutics is a clinical-stage biotechnology company developing oral therapeutic-delivery platforms for needle-free systemic delivery of large molecules and targeted therapy delivery in the gastrointestinal tract. Biora Therapeutics was founded in 2010 and is based in San Diego, California. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-01-02 |
OptiNose
Yardley, Pennsylvania, United States OptiNose is a specialty pharmaceutical company focused on the development and commercialization of products for patients cared for by, or in consultation with, ear, nose, and throat (ENT) or allergy specialists. OptiNose was founded in 2000 and is based in Yardley, Pennsylvania. |
Buy | - |
